🇺🇸 FDA
Patent

US 8273746

Methods involving aldose reductase inhibitors

granted A61KA61K31/4164A61K31/4166

Quick answer

US patent 8273746 (Methods involving aldose reductase inhibitors) held by The Board of Regents of the University of Texas System expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K31/4164, A61K31/4166, A61K31/4188, A61K31/499